Cell, Gene Therapy A No Entry Zone? EU Group Seeks Clarification Over China Regs
Should Be 'Unified And Consistent'
China’s Negative List for Foreign Investment explicitly bars “investment and application in human stem cells, genetic diagnosis, and treatment technologies.” But whether that applies to foreign pharma firms developing such modalities in the country remains unclear.
